Skip to content
10-K

Annual Report

Cogent Biosciences, Inc. COGT

0001193125-26-053334

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 162.31M sh
Shares Diluted FY 2025 · Dec 31, 2025 128.9M sh
Shares Diluted FY 2025 · Dec 31, 2024 103.86M sh
Shares Diluted FY 2025 · Dec 31, 2023 79.66M sh
Capex FY 2025 · Dec 31, 2025 $1.55M
Capex FY 2025 · Dec 31, 2024 $573K
Capex FY 2025 · Dec 31, 2023 $2.8M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$264.44M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$207.79M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$153.62M
Cash And Equivalents FY 2025 · Dec 31, 2025 $312.01M
Cash And Equivalents FY 2025 · Dec 31, 2024 $98.17M
Stockholders Equity FY 2025 · Dec 31, 2025 $636.37M
Stockholders Equity FY 2025 · Dec 31, 2024 $256.29M
Stockholders Equity FY 2025 · Dec 31, 2023 $257.8M
Stockholders Equity FY 2025 · Dec 31, 2022 $255.74M
Current Liabilities FY 2025 · Dec 31, 2025 $63.95M
Current Liabilities FY 2025 · Dec 31, 2024 $55.71M
Total Liabilities FY 2025 · Dec 31, 2025 $301.24M
Total Liabilities FY 2025 · Dec 31, 2024 $71.61M
Current Assets FY 2025 · Dec 31, 2025 $910.36M
Current Assets FY 2025 · Dec 31, 2024 $296.47M
Total Assets FY 2025 · Dec 31, 2025 $937.61M
Total Assets FY 2025 · Dec 31, 2024 $327.9M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.16
Eps Diluted FY 2025 · Dec 31, 2024 −$1.94
Eps Diluted restated FY 2025 · Dec 31, 2023 −$1.94
Eps Basic FY 2025 · Dec 31, 2025 −$2.16
Eps Basic FY 2025 · Dec 31, 2024 −$1.94
Eps Basic restated FY 2025 · Dec 31, 2023 −$1.94
Sga Expense FY 2025 · Dec 31, 2025 $63.58M
Sga Expense FY 2025 · Dec 31, 2024 $43.28M
Sga Expense FY 2025 · Dec 31, 2023 $34.38M
Rd Expense FY 2025 · Dec 31, 2025 $269.78M
Rd Expense FY 2025 · Dec 31, 2024 $232.66M
Rd Expense FY 2025 · Dec 31, 2023 $173.76M
Net Income FY 2025 · Dec 31, 2025 −$328.94M
Net Income FY 2025 · Dec 31, 2024 −$255.86M
Net Income FY 2025 · Dec 31, 2023 −$192.41M
Operating Income FY 2025 · Dec 31, 2025 −$333.36M
Operating Income FY 2025 · Dec 31, 2024 −$275.94M
Operating Income FY 2025 · Dec 31, 2023 −$208.13M